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ANOVA  Analysis of variance 
AT   Aerobic training 
BFR   Blood flow restriction 
BMI   Body mass index 
CAD   Coronary artery disease 
CCL2   Chemokine (C-C motif) ligand 2 
CET   Concurrent exercise training 
CRL   Control group 
CRP   C-reactive protein 
CVD   Cardiovascular disease 
DEXA   Dual-energy x-ray absorptiometry 
DNA   Deoxyribonucleic acid 
EDTA   Ethylenediaminetetraacetic acid 
GIP   Gastric inhibitory polypeptide 
GLP   Glucagon-like peptide 
GLUT   Glucose transporter 
HbA1c   Glycated haemoglobin 
HDL   High-density lipoprotein 
HIIT   High-intensity interval training 
HOMA-IR  Homeostasis model for assessment of insulin resistance 
HSD   Honestly significant difference 
HR   Heart rate 
HRR   Heart rate reserve 
ICAM   Intercellular adhesion molecule 
IL   Interleukin 
IQR   Interquartile range 
IRS   Insulin receptor substrate 
LDL   Low-density lipoprotein 
MCP-1  Monocyte chemoattractant protein 1 
MI   Myocardial infarction 
MMP   Matrix metalloproteinase  
mRNA   Messenger ribonucleic acid 
NAFLD  Non-alcoholic fatty liver disease 
NFκB   Nuclear factor kappa-light-chain-enhancer of activated B cells 
OGTT   Oral glucose tolerance test 
PAD   Peripheral artery disease 
PCI   Percutaneous coronary intervention 
PPO   Peak power output 
RA   Receptor antagonist 
RM   Repetition maximum 
RT   Resistance training 
SAA   Serum amyloid A 
SAT   Subcutaneous adipose tissue 
SE   Stimulus exposure 
TBFM   Total-body fat mass 
TBLM   Total-body lean mass 
TNFα   Tumour necrosis factor α 
T2DM   Type 2 diabetes mellitus 
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TUT   Time-under-tension 
VAT   Visceral adipose tissue 
VCAM  Vascular cell adhesion molecule 
VO2peak  Peak oxygen consumption 
VL   Vastus lateralis 
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This thesis examines the effects of different forms of concurrent exercise training (CET) 
on physiological biomarkers related to cardiometabolic disease risk. Specifically, a 
modification of CET to emphasise muscle time-under-tension (TUT) during the 
resistance component is examined as a potential alternative for a population of sedentary 
older adults. The present thesis seeks to compare conventional CET methods to a 
modified version (i.e. TUT) on blood-based biomarkers related to systemic inflammation, 
glucose homeostasis, and cardiovascular disease (CVD) risk. Secondary outcomes 
include whole-body and regional tissue composition, ultrasound-derived muscular 
thickness, and physical fitness measures. Further, a greater understanding of the 
relationship between training stimuli and key functional outcomes is explored.  
 
Data derived from the present investigation is presented within three distinct studies. 
Firstly, study 1 explored the effect of CET versus TUT on biomarkers related to T2DM, 
namely inflammatory cytokines (IL-6 and TNFα) and markers of glucose homeostasis, 
alongside body composition and physical capacity measures. Study 2 describes the effect 
of these training modalities on CVD-related parameters, including blood-based measures 
of platelet activity and endothelial function, as well as region-specific fat mass and 
physical fitness. Finally, study 3 examines the relationship between selected predictor 
variables (aerobic capacity, muscular strength, and whole-body lean and fat mass) and 
key prognostic disease indicators (IL-6, TNFα and insulin resistance). A secondary aim 
of study 3 is to assess the dose-specific response of CET and TUT by quantifying the 
relationship between overall training volumes and the associated changes in the 




Thirty-eight sedentary adults completed either 10 weeks of 3 sessions/week of traditional 
CET or TUT-based concurrent training. Based on baseline characteristics (age, sex, body 
mass index and fitness) participants were stratified and randomly assigned into CET 
(n=13), TUT (n=12), or a sedentary control (CRL; n=13). CET involved 30-40 min of 
resistance training using a 1.5-1.5s tempo, followed by 15-20 min of moderate-intensity 
endurance training. In contrast, TUT performed the same repetition-volume with a 3-3s 
tempo, entailing twice the time-under-tension with a reduced mechanical load (resistance 
lifted). The aerobic component was identical across both groups, comprising non-load-
bearing modalities (cycling and rowing). During the intervention period, a control group 
(CRL) was instructed to maintain habitual lifestyle behaviours. Prior to and following the 
training intervention, participants underwent testing sessions comprising a venous blood 
sample for measurement of cardiometabolic disease indicators. Also, a dual-energy x-ray 
absorptiometry (DEXA) scan provided measures of total-body lean mass (TBLM), fat 
mass (TBFM) and visceral and subcutaneous adipose tissue mass (VAT and SAT). Other 
measures included muscle ultrasound of m. vastus lateralis thickness, and assessment of 
maximal strength and endurance capacity. Pre- to post-intervention changes in these 
health-related parameters were analysed using a mixed-design analysis of variance 
(ANOVA) for detection of main effects and group x time interactions. In the presence of 
significant effects, post hoc tests using Tukey’s HSD correction located the source of 
significance at an α-level of 0.05. Moreover, Pearson’s correlations were used to quantify 
relationships between primary outcome variables, and subsequently linear regressions 
were used to investigate the relationship of the changes in relevant predictors to the 




Overall, training loads showed the between-group difference in volume-load was not 
significantly different (p=0.080), although when incorporating total lifting time-under-
tension, TUT showed a greater overall stimulus exposure (SE) (p=0.003). The key 
findings from this training intervention are that IL-6 showed a significant group x time 
interaction (p=0.017), whereby CET showed the greatest reduction of all groups 
(p=0.021). In contrast, only TUT significantly decreased TNFα (p=0.016), without any 
significant changes in any other inflammatory markers (p>0.05). Whilst all groups 
reduced plasma glucose (p<0.05), there were no significant changes in HOMA-IR or 
other glucose regulatory markers (p>0.05). Further, CVD-related markers of 
inflammatory and platelet activity showed no significant changes following training 
(p>0.05). CRP was unchanged (p>0.05), while MCP-1 increased in CRL (p=0.015), 
without significant change in CET and TUT (p>0.05). Exercise-induced reductions were 
only evident for p-selectin, which decreased in CET (p=0.009).  
 
Whole-body lean and fat mass were improved most by CET, as it was the only group to 
show a decrease in TBFM (p=0.027) and an increase in TBLM (p<0.001). In contrast, 
regional measures showed TUT provided the greatest reduction in SAT (p=0.030) and 
CET preferentially decreased VAT (p=0.049). Further, thickness of m. vastus lateralis 
showed a significant group x time interaction (p=0.002), decreasing in CRL (p=0.028) 
and increasing in CET (p=0.003). Physical fitness parameters showed a mode-specific 
response whereby CET preferentially increased quadriceps strength (p=0.001) and TUT 
provided the greatest increase in VO2peak (p<0.001). Both CET and TUT increased peak 




Linear regression analyses revealed that the change in IL-6 was explained by the change 
in strength and TBLM (y = 0.355 – (0.035 x strength) + (0.774 x TBLM)). In contrast, 
for HOMA-IR no predictors were significant in a linear regression model, and no 
significant correlations were present with any variable. The cumulative volume-load 
showed that the change in IL-6 was significantly and negatively correlated with total 
volume-load (r = -0.387, p=0.011). The change in TNFα was negatively correlated with 
total volume-load (r = -0.396, p = 0.018). However, when controlling for strength 
changes, these correlations were no longer significant. Moreover, in a linear regression 
equation volume-load was significantly associated with strength (y = 3.24 + (0.137 x 
volume-load); p = 0.023) and VO2peak (y = 0.925 + (0.013 x volume-load); p = 0.022). 
Conversely, volume-load did not significantly explain TBLM (y = 0.431 + (0.002 x 
volume-load); p = 0.072) or TBFM changes (y = 0.002 – (0.004 x volume-load); p = 
0.076).  
 
The present findings suggest that modifying the resistance component through novel 
modalities such as TUT may have small, yet relevant consequences that can aid the 
tailoring of exercise stimuli to individual needs. Specifically, although CET was superior 
to reduce IL-6, TUT showed greater decreases in TNFα. By comparison, traditional CET 
was superior to increase TBLM and muscular strength and decrease TBFM, while TUT 
preferentially decreased VAT and increased VO2peak. For individuals seeking to enhance 
body composition, physical capacity, and cardiometabolic disease indicators, 
conventional CET strategies may be most appropriate, although TUT does provide some 
distinct benefit. Importantly, increased muscular strength seems to be an important 
predictor of a decreased inflammatory milieu, and greater training volumes are associated 
with larger strength gains, recognising the standardisation of the aerobic component. Such 
xiv 
 
findings provide evidence for practitioners to tailor the exercise training stimuli from 
concurrent training to better suit the specific demands of sedentary, aged populations.  
 
The present findings will assist exercise professionals and individuals in the prescription 
of CET for older adults. In particular, the safety and efficacy shown in the current studies 
reiterates the importance of CET modalities to offset age-related increases in 
cardiometabolic risk. More specifically, conventional CET strategies incorporating 
higher RT loads may provide superior strength adaptations, while prolonged TUT 
techniques may enhance endurance parameters. Mode-specific adaptations further show 
that traditional CET can confer enhancements in body composition, alongside an anti-
inflammatory effect. Future research should investigate the role of these training 
strategies to manage existing cardiometabolic diseases, and elucidate the long-term 
effects of CET, particularly with regards to injury rates, training adherence, and 
sustainability 
 
 
 
 
 
 
 
 
